The store will not work correctly when cookies are disabled.
N-Hydroxy-2-[(3-nitro-benzenesulfonyl)-(4-nitro-benzyl)-amino]-acetamide
ID: ALA53044
PubChem CID: 11795824
Max Phase: Preclinical
Molecular Formula: C15H14N4O8S
Molecular Weight: 410.36
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(CN(Cc1ccc([N+](=O)[O-])cc1)S(=O)(=O)c1cccc([N+](=O)[O-])c1)NO
Standard InChI: InChI=1S/C15H14N4O8S/c20-15(16-21)10-17(9-11-4-6-12(7-5-11)18(22)23)28(26,27)14-3-1-2-13(8-14)19(24)25/h1-8,21H,9-10H2,(H,16,20)
Standard InChI Key: WPXAJFJACNOICK-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 29 0 0 0 0 0 0 0 0999 V2000
5.4375 -7.2250 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
4.9167 -6.9250 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.5292 -7.2167 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.0042 -5.1125 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.9625 -7.5292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3917 -7.2250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8667 -6.9250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4792 -7.2250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0000 -7.5250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1375 -7.7500 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.7500 -6.7042 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.4792 -5.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0542 -7.5167 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.5292 -5.4125 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.9167 -6.3167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5250 -6.6167 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.0042 -4.5042 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.3500 -7.2250 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.8667 -6.3167 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.9542 -5.1125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4792 -6.0167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4375 -6.0167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4375 -5.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9625 -6.3167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3500 -6.0167 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.9542 -8.1292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0042 -8.1292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4792 -8.4292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 9 1 0
4 12 1 0
5 1 1 0
6 2 1 0
7 6 1 0
8 5 1 0
9 8 2 0
10 1 2 0
11 1 2 0
12 21 2 0
13 3 1 0
14 4 1 0
15 2 1 0
16 3 2 0
17 4 2 0
18 7 2 0
19 7 1 0
20 23 2 0
21 24 1 0
22 15 1 0
23 22 1 0
24 22 2 0
25 19 1 0
26 5 2 0
27 28 2 0
28 26 1 0
9 27 1 0
12 20 1 0
M CHG 4 3 1 4 1 13 -1 14 -1
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 410.36 | Molecular Weight (Monoisotopic): 410.0532 | AlogP: 1.20 | #Rotatable Bonds: 8 |
Polar Surface Area: 172.99 | Molecular Species: NEUTRAL | HBA: 8 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 12 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 8.74 | CX Basic pKa: ┄ | CX LogP: 1.30 | CX LogD: 1.28 |
Aromatic Rings: 2 | Heavy Atoms: 28 | QED Weighted: 0.37 | Np Likeness Score: -1.77 |
References
1. Scozzafava A, Supuran CT.. (2000) Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties., 43 (9): [PMID:10794702] [10.1021/jm990594k] |